General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

Whereas the mRNA vaccines give instructions to our cells to create the coronavirus protein, the Novavax vaccine already ...

US biotech Novavax has begun a phase 1 study of its coronavirus vaccine, as the number in clinical development reached double figures. The World Health Organization has been keeping tabs on ...

"Pfizer just released its list of side effects of its COVID-19 vaccine," multiple Facebook posts said Jan. 26 and 27. The posts included a purported list of 46 Pfizer-BioNtech COVID-19 vaccine side ...

The Company has achieved a milestone associated with its Phase 2/3 clinical trial for its COVID-19 vaccine in children, triggering the first $50 million milestone payment from Sanofi. Novavax ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

The upfront payments are generous given the speculative value of Novavax's stand-alone adjuvanted COVID-19 vaccine. This is particularly true in view of the heavy expense Novavax endured in ...

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up to $1.2 billion.

Read Also: Why Novavax Stock Is Volatile This Week The news also intensified concerns about diminishing COVID-19 vaccine revenues and broader industry challenges as pandemic-driven demand ...

TORONTO — Federal funding for COVID ... 19 vaccine to match, NACI said. The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's ...